Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure.
暂无分享,去创建一个
H. Hirai | N. Kawanishi | T. Sugimoto | J. Shibata | K. Nakamura | Kouta Masutani | M. Ikuta | Nobuhiko Kawanishi
暂无分享,去创建一个
H. Hirai | N. Kawanishi | T. Sugimoto | J. Shibata | K. Nakamura | Kouta Masutani | M. Ikuta | Nobuhiko Kawanishi